Would a high Decipher score affect your recommendation regarding the addition of ADT to XRT in a favorable intermediate risk prostate patient?
Answer from: Radiation Oncologist at Community Practice
The simple answer is YES.To walk through why...1. Trials like RTOG 9408 demonstrate that there is a metastasis and OS benefit in Intermediate Risk disease from the addition of short-term ADT to RT.2. Later work from many groups showed that intermediate risk is a very heterogeneous cohort. This shoul...
Comments
Radiation Oncologist at GenesisCare USA Absolutely agree with @Daniel E. Spratt, in partic...
Radiation Oncologist at Radiant Oncology @Bridget F. Koontz - Thank you for asking this re:...
Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School Very interesting and clinically important question...
Radiation Oncologist at Jacob E Locke MD PA A favorable intermediate patient with otherwise in...
Absolutely agree with @Daniel E. Spratt, in partic...
@Bridget F. Koontz - Thank you for asking this re:...
Very interesting and clinically important question...
A favorable intermediate patient with otherwise in...